Full metadata record

DC Field Value Language
dc.contributor.authorKim, Eunhee-
dc.contributor.authorKim, Misuk-
dc.contributor.authorWoo, Dong-Hun-
dc.contributor.authorShin, Yongjae-
dc.contributor.authorShin, Jihye-
dc.contributor.authorChang, Nakho-
dc.contributor.authorOh, Young Taek-
dc.contributor.authorKim, Hong-
dc.contributor.authorRheey, Jingeun-
dc.contributor.authorNakano, Ichiro-
dc.contributor.authorLee, Cheolju-
dc.contributor.authorJoo, Kyeung Min-
dc.contributor.authorRich, Jeremy N.-
dc.contributor.authorNam, Do-Hyun-
dc.contributor.authorLee, Jeongwu-
dc.date.accessioned2024-01-20T12:03:57Z-
dc.date.available2024-01-20T12:03:57Z-
dc.date.created2021-09-05-
dc.date.issued2013-06-10-
dc.identifier.issn1535-6108-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/127968-
dc.description.abstractGlioblastoma multiforme (GBM) displays cellular hierarchies harboring a subpopulation of stem-like cells (GSCs). Enhancer of Zeste Homo log 2 (EZH2), the lysine methyltransferase of Polycomb repressive complex 2, mediates transcriptional repression of prodifferentiation genes in both normal and neoplastic stem cells. An oncogenic role of EZH2 as a transcriptional silencer is well established; however, additional functions of EZH2 are incompletely understood. Here, we show that EZH2 binds to and methylates STAT3, leading to enhanced STAT3 activity by increased tyrosine phosphorylation of STAT3. The EZH2-STAT3 interaction preferentially occurs in GSCs relative to non-stem bulk tumor cells, and it requires a specific phosphorylation of EZH2. Inhibition of EZH2 reverses the silencing of Polycomb target genes and diminishes STAT3 activity, suggesting therapeutic strategies.-
dc.languageEnglish-
dc.publisherCELL PRESS-
dc.subjectTUMOR-INITIATING CELLS-
dc.subjectGROUP PROTEIN EZH2-
dc.subjectNF-KAPPA-B-
dc.subjectHISTONE METHYLTRANSFERASE-
dc.subjectDEVELOPMENTAL REGULATORS-
dc.subjectMEDIATED REPRESSION-
dc.subjectGENE-EXPRESSION-
dc.subjectPOLYCOMB-
dc.subjectCANCER-
dc.subjectINHIBITOR-
dc.titlePhosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells-
dc.typeArticle-
dc.identifier.doi10.1016/j.ccr.2013.04.008-
dc.description.journalClass1-
dc.identifier.bibliographicCitationCANCER CELL, v.23, no.6, pp.839 - 852-
dc.citation.titleCANCER CELL-
dc.citation.volume23-
dc.citation.number6-
dc.citation.startPage839-
dc.citation.endPage852-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000320350900015-
dc.identifier.scopusid2-s2.0-84879000598-
dc.relation.journalWebOfScienceCategoryOncology-
dc.relation.journalWebOfScienceCategoryCell Biology-
dc.relation.journalResearchAreaOncology-
dc.relation.journalResearchAreaCell Biology-
dc.type.docTypeArticle-
dc.subject.keywordPlusTUMOR-INITIATING CELLS-
dc.subject.keywordPlusGROUP PROTEIN EZH2-
dc.subject.keywordPlusNF-KAPPA-B-
dc.subject.keywordPlusHISTONE METHYLTRANSFERASE-
dc.subject.keywordPlusDEVELOPMENTAL REGULATORS-
dc.subject.keywordPlusMEDIATED REPRESSION-
dc.subject.keywordPlusGENE-EXPRESSION-
dc.subject.keywordPlusPOLYCOMB-
dc.subject.keywordPlusCANCER-
dc.subject.keywordPlusINHIBITOR-
Appears in Collections:
KIST Article > 2013
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE